Solicitation of Nominations for Appointment to the Communications and Public Engagement Workgroup (CPEW) of the Advisory Committee to the Director (ACD), CDC, 15578-15579 [2024-04430]
Download as PDF
15578
Federal Register / Vol. 89, No. 43 / Monday, March 4, 2024 / Notices
comments may be made available to the
Committee for their consideration and
public distribution. Written comments
should be submitted by email to
CLIAC@cdc.gov or to the contact person
above. All written comments will be
included in the meeting minutes posted
on the CLIAC website.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–04432 Filed 3–1–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Award of a Sole Source
Cooperative Agreement To Fund
Uganda National Health Laboratories
and Diagnostic Services (NHLDS)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), located
within the Department of Health and
Human Services (HHS), announces the
award of approximately $10,000,000, for
Year 1 funding to NHLDS. The award
will strengthen laboratory systems in
Uganda by contributing to the
attainment of HIV epidemic control and
establishing sustainable and integrated
systems for quality assured disease
diagnostics, monitoring, and
surveillance. Funding amounts for years
2–5 will be set at continuation.
DATES: The period for this award will be
September 30, 2024, through September
29, 2029.
FOR FURTHER INFORMATION CONTACT:
Christina Mwangi, Center for Global
Health, Centers for Disease Control and
Prevention, US Embassy Kampala, US
Centers for Disease Control and
Prevention, 1577 Ggaba Road,
Telephone: 256772139023, Email:
mwn0@cdc.gov.
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:32 Mar 01, 2024
Jkt 262001
The sole
source award will strengthen Uganda’s
access to quality laboratory services
during the scale up of HIV prevention,
care, and treatment by supporting
implementation of the Uganda National
Health Laboratory Services (UNHLS)
Policy II (2016) and its Strategic Plan
(2020–2025).
NHLDS is in a unique position to
conduct this work, as it is the primary
stakeholder of laboratory-related policy
development, strategic planning, and
resources mobilization for the Ministry
of Health (MOH). Additionally, NHLDS
directly houses and manages the Central
Public Health Reference Laboratory
(CPHL) which is the national reference
laboratory for HIV early infant diagnosis
and viral load, national microbiology
reference laboratory, national
Tuberculosis (TB) reference laboratory,
the national laboratory biorepository
and national equipment calibration
center. Furthermore, the NHLDS is the
primary coordinator of the integrated
national laboratory specimen
transportation network that handles
both HIV, TB and outbreak specimen
referral across the country.
SUPPLEMENTARY INFORMATION:
Summary of the Award
Recipient: Uganda National Health
Laboratories and Diagnostic Services
(NHLDS).
Purpose of the Award: The purpose of
this award is to strengthen laboratory
systems in Uganda by contributing to
the attainment of HIV epidemic control
and establishing sustainable and
integrated systems for quality assured
disease diagnostics, monitoring, and
surveillance.
Amount of Award: For NHLDS, the
approximate year 1 funding amount will
be $10,000,000 in Federal Fiscal Year
(FYY) 2024 funds, subject to the
availability of funds. Funding amounts
for years 2–5 will be set at continuation.
Authority: This program is authorized
under Public Law 108–25 (the United
States Leadership Against HIV AIDS,
Tuberculosis and Malaria Act of 2003)
[22 U.S.C. 7601, et seq.] and Public Law
110–293 (the Tom Lantos and Henry J.
Hyde United States Global Leadership
Against HIV/AIDS, Tuberculosis, and
Malaria Reauthorization Act of 2008),
and Public Law 113–56 (PEPFAR
Stewardship and Oversight Act of 2013).
Period of Performance: The period for
this award will be September 30, 2024,
through September 29, 2029.
Dated: February 26, 2024.
Jamie Legier,
Acting Director, Office of Grants Services,
Centers for Disease Control and Prevention.
[FR Doc. 2024–04399 Filed 3–1–24; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Solicitation of Nominations for
Appointment to the Communications
and Public Engagement Workgroup
(CPEW) of the Advisory Committee to
the Director (ACD), CDC
ACTION:
Notice.
The Centers for Disease
Control and Prevention (CDC), within
the Department of Health and Human
Services (HHS), is seeking nominations
for membership to the Communications
and Public Engagement Workgroup
(CPEW) of the Advisory Committee to
the Director, CDC. The CPEW
workgroup consists of approximately 15
members who are experts in the fields
associated with communications,
including public relations, health
communication, risk communication,
communication research, and
marketing; community and partner
engagement; public health science and
practice, including implementation; and
behavioral science/behavior change
campaigns.
SUMMARY:
Nominations for membership on
the CPEW workgroup must be received
no later than March 28, 2024. Late
nominations will not be considered for
membership.
ADDRESSES: All nominations (cover
letters and curriculum vitae) should be
emailed to ACDirector@cdc.gov with the
subject line: ‘‘Nomination for CDC ACD
Communications and Public
Engagement Workgroup.’’
FOR FURTHER INFORMATION CONTACT: Kate
Galatas, MPH, Senior Communications
Specialist, Office of Communications,
Centers for Disease Control and
Prevention, 1600 Clifton Road (MS
H21–11), Atlanta, GA 30329–4027,
Telephone: (404) 639–2064; Email:
ACDirector@cdc.gov.
SUPPLEMENTARY INFORMATION:
Background: The purpose of the ACD,
CDC Advisory Committee to the
Director shall (1) make
recommendations to the Director
regarding ways to prioritize the
activities of the agency in alignment
with the CDC Strategic Plan required
under section 305(c); H.R. 2617–1252;
(2) advise on ways to achieve or
improve performance metrics in relation
to the CDC Strategic Plan, and other
relevant metrics, as appropriate; (3)
provide advice and recommendations
on the development of the Strategic
Plan, and any subsequent updates, as
DATES:
E:\FR\FM\04MRN1.SGM
04MRN1
khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 89, No. 43 / Monday, March 4, 2024 / Notices
appropriate; (4) advise on grants,
cooperative agreements, contracts, or
other transactions, as applicable; (5)
provide other advice to the Director, as
requested, to fulfill duties under
sections 301 and 311; and (6) appoint
subcommittees. The ACD, CDC consists
of up to 15 non-federal members,
including the Chair, knowledgeable in
areas pertinent to the CDC mission, such
as health policy, public health, global
health, preparedness, preventive
medicine, the faith-based and
community-based sector, and allied
fields.
Purpose: The establishment and
formation of the ACD, Communications
and Public Engagement Workgroup
(CPEW) is to provide input to the
Committee on agency-wide activities
related to how CDC communicates
directly and more effectively with the
public, with a focus on reaching local
communities with messages. Effective
communication with the public
includes, but is not limited to: (1)
building relationships and mechanisms
to communicate via trusted messengers,
including but not limited to, clinicians,
faith and community leaders, and health
department officials at the national,
state and local levels; (2) improving risk
communication practices; (3) delivering
more action-oriented and focused
communications to help people protect
their health (e.g., effective messages and
storytelling); (4) tailoring our messages
and communications methods, as
appropriate, to audiences, particularly
for historically marginalized
communities; and (5) increasing
transparency by stepping up the pace,
content and reach of our
communications (e.g., considering
impact of different communications
channels, such as blogs, TV interviews,
emerging platforms).
The CPEW membership consists of
approximately 15 members. It is cochaired by two current ACD, CDC
Special Government Employees. The
CPEW co-chairs will present their
findings, observations, and work
products at one or more ACD, CDC
meetings for discussion, deliberation,
and decisions (final recommendations
to CDC).
Nomination Criteria: CPEW members
will serve terms ranging from six
months to one year and be required to
attend CPEW meetings approximately
once per month (virtually or in person),
and contribute time in between
meetings for research, consultation,
discussion, and writing assignments.
Nominations are being sought for
individuals who have the expertise and
qualifications necessary to contribute to
the accomplishments of the
VerDate Sep<11>2014
17:45 Mar 01, 2024
Jkt 262001
committee’s/workgroup’s objectives.
Nominees will be selected based on
expertise in the fields of
communications, including public
relations, health communication, risk
communication, communication
research, and marketing; community
and partner engagement; public health
science and practice, including
implementation; and behavioral
science/behavior change campaigns.
Federal employees will not be
considered for membership. Selection of
members is based on candidates’
qualifications to contribute to the
accomplishment of the CPEW’s
objectives.
HHS policy stipulates that
membership be balanced in terms of
points of view represented and the
workgroup’s function. Appointments
shall be made without discrimination
based on age, race, ethnicity, gender,
sexual orientation, gender identity, HIV
status, disability, and cultural, religious,
or socioeconomic status. Nominees
must be U.S. citizens and cannot be fulltime employees of the U.S. Government.
Current participation on federal
workgroups or prior experience serving
on a federal advisory committee does
not disqualify a candidate; however,
HHS policy is to avoid excessive
individual service on advisory
committees and multiple committee
memberships. Interested candidates
should submit the following items:
• A one-half to one-page cover letter
that includes your understanding of,
and commitment to, the time and work
necessary; one to two sentences on your
background and experience; and one to
two sentences on the skills/perspective
you would bring to the CPEW.
• At least one letter of
recommendation from person(s) not
employed by the U.S. Department of
Health and Human Services.
(Candidates may submit letter(s) from
current HHS employees if they wish,
but at least one letter must be submitted
by a person not employed by an HHS
agency (e.g., CDC, NIH, FDA, etc.).
• Current curriculum vitae which
highlights the experience and work
history being sought relevant to the
criteria set forth above, including
complete contact information
(telephone numbers, mailing address,
email address).
Nominations may be submitted by the
candidate him or herself, or by the
person/organization recommending the
candidate.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
15579
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–04430 Filed 3–1–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Meeting of the Mine Safety and Health
Research Advisory Committee
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention (CDC) announces the
following meeting of the Mine Safety
and Health Research Advisory
Committee (MSHRAC). This is a hybrid
meeting, accessible both in person and
virtually. It is open to the public and
limited only by the space available and
the number of web conference lines
available. Time will be available for
public comment.
DATES: The meeting will be held on
April 17, 2024, from 8:30 a.m. to 4:10
p.m., EDT.
ADDRESSES: Mine Safety and Heath
Administration’s Approval and
Certification Center, 765 Technology
Drive, Triadelphia, West Virginia 26059.
The conference room accommodates
approximately 49 people.
Please note that the meeting location
is a Federal facility and in-person access
is limited to U.S. citizens unless prior
authorizations, taking up to 30 to 60
days, have been made.
If you wish to attend the meeting
either in person or virtually, please
contact Ms. Berni Metzger by email at
Metzger@cdc.gov or by phone at (412)
386–4541 at least 5 business days in
advance of the meeting. If you are
attending virtually, she will provide you
with the Zoom web conference access
information (500 web conference lines
are available).
FOR FURTHER INFORMATION CONTACT:
Steven Mischler, Ph.D., Designated
Federal Officer, Mine Safety and Health
SUMMARY:
E:\FR\FM\04MRN1.SGM
04MRN1
Agencies
[Federal Register Volume 89, Number 43 (Monday, March 4, 2024)]
[Notices]
[Pages 15578-15579]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-04430]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Solicitation of Nominations for Appointment to the Communications
and Public Engagement Workgroup (CPEW) of the Advisory Committee to the
Director (ACD), CDC
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), within
the Department of Health and Human Services (HHS), is seeking
nominations for membership to the Communications and Public Engagement
Workgroup (CPEW) of the Advisory Committee to the Director, CDC. The
CPEW workgroup consists of approximately 15 members who are experts in
the fields associated with communications, including public relations,
health communication, risk communication, communication research, and
marketing; community and partner engagement; public health science and
practice, including implementation; and behavioral science/behavior
change campaigns.
DATES: Nominations for membership on the CPEW workgroup must be
received no later than March 28, 2024. Late nominations will not be
considered for membership.
ADDRESSES: All nominations (cover letters and curriculum vitae) should
be emailed to [email protected] with the subject line: ``Nomination
for CDC ACD Communications and Public Engagement Workgroup.''
FOR FURTHER INFORMATION CONTACT: Kate Galatas, MPH, Senior
Communications Specialist, Office of Communications, Centers for
Disease Control and Prevention, 1600 Clifton Road (MS H21-11), Atlanta,
GA 30329-4027, Telephone: (404) 639-2064; Email: [email protected].
SUPPLEMENTARY INFORMATION:
Background: The purpose of the ACD, CDC Advisory Committee to the
Director shall (1) make recommendations to the Director regarding ways
to prioritize the activities of the agency in alignment with the CDC
Strategic Plan required under section 305(c); H.R. 2617-1252; (2)
advise on ways to achieve or improve performance metrics in relation to
the CDC Strategic Plan, and other relevant metrics, as appropriate; (3)
provide advice and recommendations on the development of the Strategic
Plan, and any subsequent updates, as
[[Page 15579]]
appropriate; (4) advise on grants, cooperative agreements, contracts,
or other transactions, as applicable; (5) provide other advice to the
Director, as requested, to fulfill duties under sections 301 and 311;
and (6) appoint subcommittees. The ACD, CDC consists of up to 15 non-
federal members, including the Chair, knowledgeable in areas pertinent
to the CDC mission, such as health policy, public health, global
health, preparedness, preventive medicine, the faith-based and
community-based sector, and allied fields.
Purpose: The establishment and formation of the ACD, Communications
and Public Engagement Workgroup (CPEW) is to provide input to the
Committee on agency-wide activities related to how CDC communicates
directly and more effectively with the public, with a focus on reaching
local communities with messages. Effective communication with the
public includes, but is not limited to: (1) building relationships and
mechanisms to communicate via trusted messengers, including but not
limited to, clinicians, faith and community leaders, and health
department officials at the national, state and local levels; (2)
improving risk communication practices; (3) delivering more action-
oriented and focused communications to help people protect their health
(e.g., effective messages and storytelling); (4) tailoring our messages
and communications methods, as appropriate, to audiences, particularly
for historically marginalized communities; and (5) increasing
transparency by stepping up the pace, content and reach of our
communications (e.g., considering impact of different communications
channels, such as blogs, TV interviews, emerging platforms).
The CPEW membership consists of approximately 15 members. It is co-
chaired by two current ACD, CDC Special Government Employees. The CPEW
co-chairs will present their findings, observations, and work products
at one or more ACD, CDC meetings for discussion, deliberation, and
decisions (final recommendations to CDC).
Nomination Criteria: CPEW members will serve terms ranging from six
months to one year and be required to attend CPEW meetings
approximately once per month (virtually or in person), and contribute
time in between meetings for research, consultation, discussion, and
writing assignments.
Nominations are being sought for individuals who have the expertise
and qualifications necessary to contribute to the accomplishments of
the committee's/workgroup's objectives. Nominees will be selected based
on expertise in the fields of communications, including public
relations, health communication, risk communication, communication
research, and marketing; community and partner engagement; public
health science and practice, including implementation; and behavioral
science/behavior change campaigns. Federal employees will not be
considered for membership. Selection of members is based on candidates'
qualifications to contribute to the accomplishment of the CPEW's
objectives.
HHS policy stipulates that membership be balanced in terms of
points of view represented and the workgroup's function. Appointments
shall be made without discrimination based on age, race, ethnicity,
gender, sexual orientation, gender identity, HIV status, disability,
and cultural, religious, or socioeconomic status. Nominees must be U.S.
citizens and cannot be full-time employees of the U.S. Government.
Current participation on federal workgroups or prior experience serving
on a federal advisory committee does not disqualify a candidate;
however, HHS policy is to avoid excessive individual service on
advisory committees and multiple committee memberships. Interested
candidates should submit the following items:
A one-half to one-page cover letter that includes your
understanding of, and commitment to, the time and work necessary; one
to two sentences on your background and experience; and one to two
sentences on the skills/perspective you would bring to the CPEW.
At least one letter of recommendation from person(s) not
employed by the U.S. Department of Health and Human Services.
(Candidates may submit letter(s) from current HHS employees if they
wish, but at least one letter must be submitted by a person not
employed by an HHS agency (e.g., CDC, NIH, FDA, etc.).
Current curriculum vitae which highlights the experience
and work history being sought relevant to the criteria set forth above,
including complete contact information (telephone numbers, mailing
address, email address).
Nominations may be submitted by the candidate him or herself, or by
the person/organization recommending the candidate.
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-04430 Filed 3-1-24; 8:45 am]
BILLING CODE 4163-18-P